Siponimod: A New Approved Oral Drug to Treat Multiple Sclerosis

NeuroPharmac Journal
doi 10.37881/1.421
Full Text
Abstract

Available in full text

Date
Authors
Publisher

NeuroPharmac Journal

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy